Naturally gluten-free foods
Harvard study: Healthier fats linked to longer life after prostate cancer diagnosis
Shingrix shingles vaccine linked with lower heart disease risks
Estrogen-only hormone therapy tied to lower dementia risk
Should you have a hysterectomy?
Stair climbing may significantly lower cardiovascular risks
Why do I sweat so much?
Walking pneumonia: The "mild" illness that can still pack a punch
What causes knee pain: How doctors make a diagnosis
Where you carry excess weight matters in predicting heart disease risk
Healthy eating for diabetes Archive
Articles
Waist-to-hip ratio better than BMI in predicting future health issues
According to a 2023 study, a person's waist-to-hip ratio-the circumference of the waist divided by the circumference of the hip-is a better predictor of future health issues like high blood pressure, heart disease, and type 2 diabetes than body mass index.
Prebiotics in plant-based foods may help control unhealthy eating
A 2023 study suggests eating more prebiotics-compounds found in plant fiber that nourish healthy bacteria in the gut-may affect the brain's reward network in a way that helps people make healthier food choices.
How healthy is sugar alcohol?
Food products advertised as being lower in sugar or sugar-free contain sugar substitutes. Sugar alcohol is another ingredient used as a sweetener in food products. But is sugar alcohol a better choice nutritionally than other sweeteners or natural sugar?
Do toddler formulas deliver on nutrition claims?
Formula companies claim that toddler formulas, also known as "follow-up formulas," "transition formulas," or "growing-up milks" offer nutritional benefits to toddlers. But are these products necessary and healthy?
Prediabetes linked to higher risk of cardiovascular problems
Even slightly elevated blood sugar levels—a condition known as pre-diabetes—may raise the risk of cardiovascular problems. But attention to weight loss and greater use of medications to lower blood pressure and cholesterol appear to reduce the risk.
Understanding new weight-loss drugs
A newer class of medications used to treat type 2 diabetes called glucagon-like peptide-1 (GLP-1) receptor agonists has gained attention because of their impressive weight-loss results—in many cases, 10% to 20% of a person's body weight. Versions of two of these GLP-1 receptor agonists, liraglutide (Saxenda) and semaglutide (Wegovy), are FDA-approved for weight loss, even for people without diabetes. However, there isn't enough evidence to know whether these drugs might be beneficial or dangerous for people who are not diagnosed with diabetes or obesity.
Naturally gluten-free foods
Harvard study: Healthier fats linked to longer life after prostate cancer diagnosis
Shingrix shingles vaccine linked with lower heart disease risks
Estrogen-only hormone therapy tied to lower dementia risk
Should you have a hysterectomy?
Stair climbing may significantly lower cardiovascular risks
Why do I sweat so much?
Walking pneumonia: The "mild" illness that can still pack a punch
What causes knee pain: How doctors make a diagnosis
Where you carry excess weight matters in predicting heart disease risk
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!
Sign Up